Asston Pharmaceuticals Announces Board Appointments and Meeting
Asston Pharmaceuticals Ltd. announced that a meeting of its Board of Directors will be held on March 30, 2026, at 3:00 P.M. Several key appointments are on the agenda for the meeting.The Board will consider the appointment of Mr. Sumit Pawar as Chief Financial Officer. Additionally, the company will review the potential appointments of Mr. Yashvardhan Tupe as an Additional Non-Executive Director and Mr. Sandip Sharma as an Additional Non-Executive Independent Director.
The meeting will also include a review of a circular resolution regarding the appointment of a statutory auditor and consideration of the date and notice for an Extraordinary General Meeting. Other incidental matters will also be addressed during the meeting.
The company's BSE Code is 544445, and its ISIN is INE0SJX01015.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.